The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell(S) | 1K | $43.67 | $48K |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell(S) | 10K | $42.89 | $446K |
| Sep 4, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell(S) | 3K | $43.66 | $118K |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 2K | $42.81 | $106K |
| Sep 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 1K | $43.71 | $51K |
| Sep 4, 2026 | McGuire Annie | EVP, General Counsel | Sell(S) | 2K | $42.79 | $92K |
| Sep 2, 2026 | Stapley Marc | Chief Executive Officer, Director | Tax withholding(F) | 9K | $44.88 | $394K |
| Sep 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding(F) | 1K | $44.88 | $61K |
| Sep 2, 2026 | Leite John | Global Chief Commercial Off | Tax withholding(F) | 4K | $44.88 | $178K |
| Sep 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding(F) | 4K | $44.88 | $163K |
| Sep 2, 2026 | Chambers Rebecca | Chief Financial Officer | Tax withholding(F) | 4K | $44.88 | $162K |
| Sep 2, 2026 | McGuire Annie | EVP, General Counsel | Tax withholding(F) | 3K | $44.88 | $144K |
| Sep 1, 2026 | Bhanji Muna | Director | Sell(S) | 2K | $42.97 | $80K |
| Jun 18, 2026 | Eastham Karin | Director | Sell(S) | 3K | $52.78 | $169K |
| Jun 18, 2026 | Eastham Karin | Director | Sell(S) | 529 | $53.55 | $28K |
| Jun 11, 2026 | Jones Evan/ Fa | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Barr Eliav | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Eastham Karin | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Shafer David Brent | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Epstein Robert S | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Holstein Jens | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Bhanji Muna | Director | Grant(A) | 5K | — | $0 |
| Jun 11, 2026 | Miller Thomas F. | Director | Grant(A) | 5K | — | $0 |
| Jun 4, 2026 | McGuire Annie | EVP, General Counsel | Sell(S) | 1K | $49.31 | $69K |
| Jun 4, 2026 | McGuire Annie | EVP, General Counsel | Sell(S) | 2K | $50.12 | $89K |
| Jun 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 2K | $49.28 | $79K |
| Jun 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 2K | $50.09 | $98K |
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer, Director | Option exercise(M) | 138K | $36.60 | $5.1M |
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer, Director | Sell(S) | 138K | $50.12 | $6.9M |
| Jun 4, 2026 | Stapley Marc | Chief Executive Officer, Director | Option exercise(M) | 138K | — | $0 |
| Jun 4, 2026 | Leite John | Global Chief Commercial Off | Sell(S) | 14K | $50.07 | $700K |
| Jun 2, 2026 | McGuire Annie | EVP, General Counsel | Tax withholding(F) | 3K | $47.80 | $157K |
| Jun 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding(F) | 1K | $47.80 | $65K |
| Jun 2, 2026 | Chambers Rebecca | Chief Financial Officer | Tax withholding(F) | 4K | $47.80 | $177K |
| Jun 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding(F) | 4K | $47.80 | $178K |
| Jun 2, 2026 | Stapley Marc | Chief Executive Officer, Director | Tax withholding(F) | 9K | $47.80 | $431K |
| Jun 2, 2026 | Leite John | Global Chief Commercial Off | Tax withholding(F) | 4K | $47.80 | $194K |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Option exercise(M) | 24K | $24.80 | $595K |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Sell(S) | 24K | $45.40 | $1.1M |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Option exercise(M) | 24K | — | $0 |
| May 20, 2026 | Epstein Robert S | Director | Sell(S) | 10K | $44.01 | $440K |
| May 6, 2026 | McGuire Annie | SVP, General Counsel | Sell(S) | 5K | $38.05 | $194K |
| May 6, 2026 | McGuire Annie | SVP, General Counsel | Sell(S) | 5K | $40.00 | $204K |
| Apr 10, 2026 | Haas Kevin Richard | Chief Dev and Tech Officer | Grant(A) | 44K | — | $0 |
| Mar 6, 2026 | Stapley Marc | Chief Executive Officer, Director | Grant(A) | 92K | — | $0 |
| Mar 6, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Grant(A) | 11K | — | $0 |
| Mar 6, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Grant(A) | 7K | — | $0 |
| Mar 6, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Grant(A) | 30K | — | $0 |
| Mar 6, 2026 | Chambers Rebecca | Chief Financial Officer | Grant(A) | 36K | — | $0 |
| Mar 6, 2026 | Chambers Rebecca | Chief Financial Officer | Grant(A) | 13K | — | $0 |
| Mar 6, 2026 | McGuire Annie | SVP, General Counsel | Grant(A) | 33K | — | $0 |
| Mar 6, 2026 | McGuire Annie | SVP, General Counsel | Grant(A) | 26K | — | $0 |
| Mar 6, 2026 | Leite John | Chief Commercial Officer-CLIA | Grant(A) | 7K | — | $0 |
| Mar 6, 2026 | Leite John | Chief Commercial Officer-CLIA | Grant(A) | 36K | — | $0 |
| Mar 4, 2026 | Stapley Marc | Chief Executive Officer, Director | Sell(S) | 26K | $36.28 | $953K |
| Mar 4, 2026 | Stapley Marc | Chief Executive Officer, Director | Sell(S) | 19K | $35.56 | $684K |
| Mar 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 14K | $36.33 | $506K |
| Mar 4, 2026 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 4K | $35.55 | $156K |
| Mar 4, 2026 | McGuire Annie | SVP, General Counsel | Sell(S) | 5K | $35.29 | $176K |
| Mar 4, 2026 | McGuire Annie | SVP, General Counsel | Sell(S) | 2K | $36.34 | $60K |
| Mar 4, 2026 | Leite John | Chief Commercial Officer-CLIA | Sell(S) | 5K | $35.19 | $185K |
| Mar 2, 2026 | Stapley Marc | Chief Executive Officer, Director | Tax withholding(F) | 19K | $36.01 | $701K |
| Mar 2, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding(F) | 3K | $36.01 | $108K |
| Mar 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell(S) | 13K | $36.16 | $485K |
| Mar 2, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding(F) | 6K | $36.01 | $217K |
| Mar 2, 2026 | Chambers Rebecca | Chief Financial Officer | Tax withholding(F) | 7K | $36.01 | $260K |
| Mar 2, 2026 | McGuire Annie | SVP, General Counsel | Tax withholding(F) | 7K | $36.01 | $249K |
| Mar 2, 2026 | Leite John | Chief Commercial Officer-CLIA | Tax withholding(F) | 8K | $36.01 | $271K |
| Feb 26, 2026 | Stapley Marc | Chief Executive Officer, Director | Grant(A) | 139K | — | $0 |
| Feb 26, 2026 | Stapley Marc | Chief Executive Officer, Director | Tax withholding(F) | 36K | $38.75 | $1.4M |
| Feb 26, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding(F) | 24K | $38.75 | $949K |
| Feb 26, 2026 | Febbo Phillip G. | Chief Scientific & Med Officer | Grant(A) | 72K | — | $0 |
| Feb 26, 2026 | Chambers Rebecca | Chief Financial Officer | Grant(A) | 59K | — | $0 |
| Feb 26, 2026 | Chambers Rebecca | Chief Financial Officer | Tax withholding(F) | 12K | $38.75 | $467K |
| Feb 26, 2026 | McGuire Annie | SVP, General Counsel | Grant(A) | 51K | — | $0 |
| Feb 26, 2026 | McGuire Annie | SVP, General Counsel | Tax withholding(F) | 11K | $38.75 | $421K |
| Feb 26, 2026 | Leite John | Chief Commercial Officer-CLIA | Grant(A) | 47K | — | $0 |
| Feb 26, 2026 | Leite John | Chief Commercial Officer-CLIA | Tax withholding(F) | 9K | $38.75 | $345K |
| Dec 16, 2025 | McGuire Annie | SVP, General Counsel | Sell(S) | 11K | $43.13 | $459K |
| Dec 16, 2025 | McGuire Annie | SVP, General Counsel | Sell(S) | 100 | $43.68 | $4K |
| Dec 5, 2025 | Eastham Karin | Director | Option exercise(M) | 10K | $7.94 | $79K |
| Dec 5, 2025 | Eastham Karin | Director | Option exercise(M) | 10K | $7.60 | $76K |
| Dec 5, 2025 | Eastham Karin | Director | Sell(S) | 800 | $46.59 | $37K |
| Dec 5, 2025 | Eastham Karin | Director | Sell(S) | 13K | $45.84 | $587K |
| Dec 5, 2025 | Eastham Karin | Director | Sell(S) | 6K | $44.52 | $285K |
| Dec 5, 2025 | Eastham Karin | Director | Option exercise(M) | 10K | — | $0 |
| Dec 5, 2025 | Eastham Karin | Director | Option exercise(M) | 10K | — | $0 |
| Dec 4, 2025 | Stapley Marc | Chief Executive Officer, Director | Sell(S) | 4K | $46.90 | $209K |
| Dec 4, 2025 | Stapley Marc | Chief Executive Officer, Director | Sell(S) | 3K | $47.35 | $152K |
| Dec 4, 2025 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 5K | $47.25 | $224K |
| Dec 4, 2025 | Chambers Rebecca | Chief Financial Officer | Sell(S) | 9K | $46.61 | $398K |
| Dec 4, 2025 | McGuire Annie | SVP, General Counsel | Sell(S) | 720 | $47.10 | $34K |
| Dec 4, 2025 | McGuire Annie | SVP, General Counsel | Sell(S) | 702 | $47.51 | $33K |
| Dec 4, 2025 | Leite John | Chief Commercial Officer-CLIA | Sell(S) | 1K | $47.51 | $61K |
| Dec 2, 2025 | Stapley Marc | Chief Executive Officer, Director | Tax withholding(F) | 8K | $46.16 | $365K |
| Dec 2, 2025 | Wygant Jonathan | VP, Chief Accounting Officer | Tax withholding(F) | 1K | $46.16 | $61K |
| Dec 2, 2025 | Febbo Phillip G. | Chief Scientific & Med Officer | Tax withholding(F) | 3K | $46.16 | $136K |
| Dec 2, 2025 | Chambers Rebecca | Chief Financial Officer | Tax withholding(F) | 3K | $46.16 | $156K |
| Dec 2, 2025 | McGuire Annie | SVP, General Counsel | Tax withholding(F) | 3K | $46.16 | $141K |
| Dec 2, 2025 | Leite John | Chief Commercial Officer-CLIA | Tax withholding(F) | 3K | $46.16 | $134K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Veracyte, Inc., SEC CIK 0001384101. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under VCYT and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for VCYT